Correlation of baseline clinical characteristics and laparoscopic extent of carcinomatosis of women with initially unresectable ovarian, tubal or peritoneal adenocarcinoma, in ANTHALYA study: A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant

Roman Rouzier; Sebastien Gouy; Frédéric Selle; Eric Lambaudie; Frederic Guyon; Virginie Fourchotte; Christophe Pomel; Pierre Emmanuel Colombo; Elsa Kalbacher; Sandrine Martin; Raffaele Fauvet; Philippe Follana; Anne Lesoin; Fabrice Lecuru; Violette Menguy; Youssef Ghazi; Elisabeth Chereau; Sarah Zohar; Paul H. Cottu; Florence Joly

doi:10.1200/jco.2015.33.15_suppl.5538

Retour

Correlation of baseline clinical characteristics and laparoscopic extent of carcinomatosis of women with initially unresectable ovarian, tubal or peritoneal adenocarcinoma, in ANTHALYA study: A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant

Article de revue

Avec comité de lecture

Correlation of baseline clinical characteristics and laparoscopic extent of carcinomatosis of women with initially unresectable ovarian, tubal or peritoneal adenocarcinoma, in ANTHALYA study: A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant

Roman Rouzier, Sebastien Gouy, Frédéric Selle, Eric Lambaudie, Frederic Guyon, Virginie Fourchotte, Christophe Pomel, Pierre Emmanuel Colombo, Elsa Kalbacher, Sandrine Martin, …

Journal of clinical oncology, Vol.33(15_suppl), pp.5538-5538

20/05/2015

DOI: https://doi.org/10.1200/jco.2015.33.15_suppl.5538

Résumé

Abstract only

Indicateurs

1 Consultations de la notice

Détails

Titre: Correlation of baseline clinical characteristics and laparoscopic extent of carcinomatosis of women with initially unresectable ovarian, tubal or peritoneal adenocarcinoma, in ANTHALYA study: A randomized, open-label, phase II study assessing the efficacy and the safety of bevacizumab in neoadjuvant
Créateurs - sans rôle: Roman Rouzier - Insitut Curie, Paris, France
Sebastien Gouy - Department of Surgery, Institut Gustave Roussy, Villejuif, France
Frédéric Selle - Universite Pierre et Marie Curie, Oncology, GHU-Est Tenon, Paris, France
Eric Lambaudie - Institut Paoli-Calmettes
Frederic Guyon - Institut Bergonié
Virginie Fourchotte - Institut Curie
Christophe Pomel - Centre Jean Perrin
Pierre Emmanuel Colombo - Montpellier Cancer Institute, Montpellier, France
Elsa Kalbacher - CHU Besançon, Besançon, France
Sandrine Martin - Centre François Baclesse, Caen, France
Raffaele Fauvet - CHU Amiens, Amiens, France
Philippe Follana - Centre Antoine Lacassagne
Anne Lesoin - Centre Oscar Lambret
Fabrice Lecuru - European Georges Pompidou Hospital, Paris, France
Violette Menguy - Roche, Boulogne, France
Youssef Ghazi - Roche, Boulogne-Billancourt, France
Elisabeth Chereau - Institut Paoli Calmette, Marseille, France
Sarah Zohar - Centre de Recherche des Cordeliers
Paul H. Cottu - Institut Curie
Florence Joly - Centre François Baclesse, Caen, France
Détails de publication: Journal of clinical oncology, Vol.33(15_suppl), pp.5538-5538
Identifiants: 99140161809311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM
Langue: English
Type de ressource: Journal article